Leap Therapeutics Inc. buy krebskrebs
Start price
14.06.21
/
50%
€15.38
Target price
14.06.22
€30.00
Performance (%)
-42.16%
End price
15.06.22
€8.90
Summary
This prediction ended on 15.06.22 with a price of €8.90. The BUY prediction by krebskrebs for Leap Therapeutics Inc. performed very badly with a performance of -42.16%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Leap Therapeutics Inc. | -7.273% | -7.273% | -63.043% | -76.712% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by krebskrebs for this prediction
In the thread Leap Therapeutics Inc diskutieren
In the thread Trading Leap Therapeutics Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten